GGrantScoutHQCreate alert

Grants for Public and state-controlled institutions of higher education — Page 2

Current opportunities whose structured applicant data includes Public and state-controlled institutions of higher education. Confirm entity definitions, geography, registrations, exclusions and every other condition in the official notice.

418 current opportunities · showing 25–48

OPENHealth & Medical

Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) invites applications proposing a Data Coordinating Center that integrates and disseminates multiscale mouse brain datasets for the aging and Alzheimer's disease (AD) research community. The Data Coordinating Center will establish the Aging and AD Mouse

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $2,500,000
Check fit and official source →
OPENHealth & Medical

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for an Infectious Diseases Clinical Trials Network (IDCTN). The IDCTN, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of interventions for em

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $10,000,000
Check fit and official source →
OPENHealth & Medical

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to support a Clinical Research Network (CRN) on Antimicrobial Resistance (AMR). The program aims to design, implement, and manage clinical research that addresses pivotal clinical questions related to AMR through a coordinated and integrate

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $18,000,000
Check fit and official source →
OPENHealth & Medical

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular charact

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $5,900,000
Check fit and official source →
OPENHealth & Medical

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecim

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $5,100,000
Check fit and official source →
OPENHealth & Medical

Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)

National Institutes of Health

The Common Fund Human Virome Program (HVP) aims to extensively and comprehensively characterize the "healthy" human virome (the collection of viruses that normally reside inside the human body without evidence of disease) and create tools, models, and methods that will enable an in-depth s

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $2,000,000
Check fit and official source →
OPENHealth & Medical

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $40,000,000
Check fit and official source →
OPENSmall Business & Startups

Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) announces the renewal of the NIH Research Evaluation and Commercialization Hub (REACH) program, established to facilitate and accelerate the translation of academic biomedical discoveries into products that improve patient care and public health. Through thi

Deadline
Nov 11, 2026
Funding
Estimated total program funding: $5,000,000
Check fit and official source →
OPENHealth & Medical

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, dietary supplements, and probiotics), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural p

Deadline
Nov 14, 2026
Funding
Estimated total program funding: $1,050,000
Check fit and official source →
OPENHealth & Medical

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

National Institutes of Health

This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that propose to support intensive supervised research training and career development experiences for clinician scientists (Scholars) leading to research independence in t

Deadline
Nov 14, 2026
Funding
Up to $750,000
Check fit and official source →
OPENHealth & Medical

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated mid-phase clinical trials of natural products(i.e., botanicals, dietary supplements, and probiotics), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural produc

Deadline
Nov 14, 2026
Funding
Estimated total program funding: $350,000
Check fit and official source →
OPENHealth & Medical

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, probiotics, and products marketed as dietary supplements), which have a strong scientific premise to justify further clinical testing. For

Deadline
Nov 14, 2026
Funding
Estimated total program funding: $350,000
Check fit and official source →
OPENGeneral Funding

OJJDP FY 2026 Strategies to Support Children Exposed to Violence

Office of Juvenile Justice Delinquency Prevention

This is a notice of funding opportunity (NOFO) for the OJJDP FY 2026 Strategies to Support Children Exposed to Violence. This opportunity will support the implementation of violent crime reduction strategies focused on violent juvenile offenders and improving communities' ability to help childr

Deadline
Nov 17, 2026
Funding
Estimated total program funding: $7,335,000
Check fit and official source →
OPENResearch & Science

NIJ FY 2026 Research and Evaluation on Human Trafficking

National Institute of Justice

This is a notice of funding opportunity (NOFO) for the NIJ FY 2026 Research and Evaluation on Human Trafficking. This opportunity supports proposals for rigorous research and evaluation projects to better understand, respond to, and reduce Human Trafficking in the United States in three areas: (1) p

Deadline
Nov 17, 2026
Funding
Estimated total program funding: $2,500,000
Check fit and official source →
OPENResearch & Science

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to invite Small Research Grant (R21) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Direct involve

Deadline
Nov 17, 2026
Funding
Up to $50,000
Check fit and official source →
OPENResearch & Science

NIJ FY 2026 Research and Evaluation on Justice System Responses to Illegal Immigration

National Institute of Justice

This is a notice of funding opportunity (NOFO) for the NIJ FY 2026 Research and Evaluation on Justice System Responses to Illegal Immigration. This opportunity supports proposals for rigorous, applied research and evaluations examining the adult criminal justice system (courts, law enforcement, jail

Deadline
Nov 17, 2026
Funding
Estimated total program funding: $3,000,000
Check fit and official source →
OPENResearch & Science

NIJ FY 2026 Crime and Justice Research

National Institute of Justice

This is a notice of funding opportunity (NOFO) for the NIJ FY 2026 Crime and Justice Research. This opportunity NOFO calls for applications in two categories: Category 1: Crime and Justice Research: Category 1 will support applications for research on new programs, strategies, and technological solu

Deadline
Nov 17, 2026
Funding
Estimated total program funding: $5,500,000
Check fit and official source →
OPENResearch & Science

NIJ FY 2026 Evaluation of the Effectiveness of the Bureau of Justice Assistance (BJA) Byrne State Crisis Intervention Program (SCIP)

National Institute of Justice

This is a notice of funding opportunity (NOFO) for the NIJ FY 2026 Evaluation of the Effectiveness of the Bureau of Justice Assistance (BJA) Byrne State Crisis Intervention Program (SCIP).1 This opportunity will support research and evaluation to assess the effectiveness of programs funded under FYs

Deadline
Nov 17, 2026
Funding
Estimated total program funding: $23,773,974
Check fit and official source →
OPENHealth & Medical

OJJDP FY 2026 Mentoring for Youth Impacted by Opioids and Other Substance Use

Office of Juvenile Justice Delinquency Prevention

This is a notice of funding opportunity (NOFO) for the OJJDP FY 2026 Mentoring for Youth Impacted by Opioids and Other Substance Use program. This opportunity supports the implementation and delivery of high-quality mentoring services for youth who are currently using or dependent on substances, as

Deadline
Nov 17, 2026
Funding
Estimated total program funding: $16,500,000
Check fit and official source →
OPENGeneral Funding

OJJDP FY 2026 Internet Crimes Against Children On-Line Child Protection System (ICACCOPS)

Office of Juvenile Justice Delinquency Prevention

This is a notice of funding opportunity (NOFO) for the OJJDP FY 2026 Internet Crimes Against Children On-Line Child Protection System (ICACCOPS). This opportunity supports maintenance of and enhancements to the Internet Crimes Against Children On-line Child Protection System (ICACCOPS) investigative

Deadline
Nov 17, 2026
Funding
Estimated total program funding: $900,000
Check fit and official source →
OPENHealth & Medical

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

National Institutes of Health

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to el

Deadline
Nov 18, 2026
Funding
Estimated total program funding: $200,000
Check fit and official source →
OPENHealth & Medical

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenatal alcohol exposure and the incidenc

Deadline
Nov 18, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy or effectiveness of complementary and integrative health interventions in NCCIH- designated areas of high research priority. Appl

Deadline
Nov 18, 2026
Funding
See official notice
Check fit and official source →
OPENHealth & Medical

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

National Institutes of Health

The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) for conditions that have been identified by NCCIH as high-priorit

Deadline
Nov 18, 2026
Funding
See official notice
Check fit and official source →

Before you apply

Applicant type is only the first screening step. Check location, project purpose, cost share, required partners, registration lead time and the funder’s definition of an eligible entity.